Subscribe: MedWorm: Cancer & Oncology
http://www.medworm.com/rss/medicalfeeds/specialities/Cancer-Oncology.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
breast cancer  cancer  health  medical  medscape  medworm message  medworm  new  news  oncology  prostate cancer  sales  source 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Cancer & Oncology

MedWorm: Cancer & Oncology News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Cancer & Oncology



Last Build Date: Sun, 25 Feb 2018 09:27:11 +0100

 



A mother Googled her toddler ’ s symptoms — and believes it may have saved the child ’ s life

Sat, 24 Feb 2018 14:00:10 +0100

It was a headline that captured her attention: “Boy, 13, died just A WEEK after being diagnosed with leukemia despite having NO symptoms beforehand.” Laura Handley, a mother of five, had been scrolling through Facebook when she was sucked into a story about a seemingly healthy 13-year-old boy who had died suddenly from an aggressive form of cancer called acute myeloid […]Related:Here’s what you should know about the flu season this yearFlu cases fall for the first time this awful influenza seasonCDC seeks new labs for bioterror pathogens to replace aging facility (Source: Washington Post: To Your Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Nigeria:'15,000 Nigerian Women Die Annually From Breast Cancer'

Sat, 24 Feb 2018 07:29:44 +0100

[Daily Trust] About 15, 000 women in the country die of breast cancer annually, a medical oncologist, specialized in breast cancer, Dr Bisi Ademuyiwa has said. She disclosed this yesterday during a seminar organized by AXA Mansard HMO in collaboration with the African Women's Entrepreneurship Program (AWEP) in Abuja. (Source: AllAfrica News: Health and Medicine)



The Rules of the Road

Sat, 24 Feb 2018 06:07:34 +0100

A review of the rules of the road for doctors, because everyone remembers their first license. (Source: CancerNetwork)



New genetic link reveals some ovarian cancer passed down by fathers

Sat, 24 Feb 2018 01:37:44 +0100

(Source: CNN.com - Health)



Emily Dumler receives new immunotherapy cancer treatment

Sat, 24 Feb 2018 00:08:40 +0100

Emily Dumler, 36, was diagnosed with stage three non-Hogdkin's Lymphoma in September 2013 and given months to live. But an immunotherapy clinical trial saved her live. (Source: the Mail online | Health)



Why Some Are Still Skeptical of Tanning Bed Risks

Sat, 24 Feb 2018 00:00:00 +0100

(Source: Cancercompass News: Other Cancer)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Mother-of-3 receives new immunotherapy cancer treatment

Fri, 23 Feb 2018 23:16:28 +0100

Emily Dumler, 36, was diagnosed with stage three non-Hogdkin's Lymphoma in September 2013 and given months to live. But an immunotherapy clinical trial saved her live. (Source: the Mail online | Health)



Why Some Are Still Skeptical of Tanning Bed Risks

Fri, 23 Feb 2018 22:00:00 +0100

(Source: The Doctors Lounge - Oncology)



Karmanos Multiple Myeloma cancer patient and his oncologist prepare for the hike of a lifetime

Fri, 23 Feb 2018 21:14:12 +0100

(Source: Karmanos Cancer Institute)



Enzalutamide'Encouraging' in Hormone- Naive Prostate Cancer Enzalutamide'Encouraging' in Hormone- Naive Prostate Cancer

Fri, 23 Feb 2018 20:50:46 +0100

Enzalutamide may have a role in prostate cancer therapy, but randomized trials are needed, says Dr Chodak.Medscape Urology (Source: Medscape Today Headlines)



U.S. Rep. Joseph Crowley Visits with Cancer Peer Mentors of the BOLD Program at Einstein

Fri, 23 Feb 2018 20:33:36 +0100

February 23, 2018—(BRONX, NY)—Earlier this week, in a crowded conference room in the Price Center/Block Pavilion, members of the Einstein-Montefiore community hosted a special visit from U.S. Congressman Joseph Crowley (D-NY, 14th District). At his office’s request, Rep. Crowley met with more than a dozen BOLD Buddies, volunteer peer mentors who provide support for cancer patients and survivors in the Bronx. Members of the group shared their personal stories and explained commitment to offer their support, hope and encouragement to others facing cancer and treatment at all stages of disease. (Source: Einstein News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Kidney cancer warning - why you should never ignore a pain in your side

Fri, 23 Feb 2018 19:45:00 +0100

CANCER symptoms usually include an unexplained change in the body ’s normal processes. But, having a pain in your side that doesn’t go away could be a sign of kidney cancer, and you should see a doctor. (Source: Daily Express - Health)



EU Says Yes to Mylotarg for AML, No to Adjuvant Sunitinib EU Says Yes to Mylotarg for AML, No to Adjuvant Sunitinib

Fri, 23 Feb 2018 19:25:42 +0100

Gemtuzumab ozogamicin (Mylotarg) has been recommended for approval in Europe for use in acute myeloid leukemia, but adjuvant sunitinib after kidney cancer surgery was turned down.International Approvals (Source: Medscape Medical News Headlines)



See how Norton Healthcare is tailoring its new $38 million cancer center (PHOTOS)

Fri, 23 Feb 2018 19:17:26 +0100

Norton Healthcare is customizing treatment rooms for the best patient and provider experience. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)



ctDNA Can Flag Pseudoprogression in Melanoma Treated With Immunotherapy

Fri, 23 Feb 2018 19:11:26 +0100

Circulating tumor DNA can help differentiate pseudoprogression from true progression in patients with melanoma who are treated with PD-1 inhibitors. (Source: CancerNetwork)



SBRT Then Pembrolizumab: Well Tolerated in Met Tumors

Fri, 23 Feb 2018 19:11:26 +0100

The significant tumor shrinkage and immunologic changes observed support a complementary role of SBRT and PD-1 immunotherapy, investigators concluded. (Source: CancerNetwork)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




High Response Rates With Larotrectinib in Tumor Types With TRK Fusions

Fri, 23 Feb 2018 19:11:26 +0100

Early-phase data on larotrectinib validate TRK fusions as therapeutic targets and show they lead to tumor-agnostic sensitivity to this agent. (Source: CancerNetwork)



Europe Says No to Neratinib for Breast Cancer Europe Says No to Neratinib for Breast Cancer

Fri, 23 Feb 2018 19:05:32 +0100

The European committee recommended against approval of neratinib (Nerlynx) for breast cancer, even though the drug has been approved in the United States.International Approvals (Source: Medscape Hematology-Oncology Headlines)



Pancreatitis Raises Risk of Later Cancer

Fri, 23 Feb 2018 19:00:00 +0100

(MedPage Today) -- Likelihood of pancreatic cancer increased beyond 5 years after the acute episode (Source: MedPage Today Primary Care)



Kenneth Seddon obituary

Fri, 23 Feb 2018 18:40:46 +0100

Pioneer of ‘green chemistry’ through his groundbreaking research into ionic liquidsKenneth Seddon, who has died aged 67 after suffering from cancer, was apioneering chemistand acknowledged leader of “green chemistry”. He led the growth of research into a relatively new area of study,ionic liquids.Ken did not discover these substances, but in the 1980s he was the first to see that they were an unexplored form of matter with huge potential. Unlike everyday molecular solvents, such as water, acetone (nail varnish remover) or petrol, which are uncharged, these liquid salts consist of disparately shaped positive and negative ions. This gives the liquids high electric fields, and therefore high solubilities. It also means they mostly do not release fumes, evaporate or boil. Ken realised ...



WATCH: Woman becomes sister's surrogate

Fri, 23 Feb 2018 18:01:35 +0100

Erin Silverman carried a baby for her sister, Randi Fishman, who was diagnosed with breast cancer at age 28. (Source: ABC News: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Growth Rates of Small Renal Masses Highly Variable Early On

Fri, 23 Feb 2018 18:00:00 +0100

Not reliable predictor of adverse outcomes in those under active surveillance; less variability over time (Source: The Doctors Lounge - Oncology)



Dermoscopic Criteria Identified for Diagnosing Melanoma in Situ

Fri, 23 Feb 2018 18:00:00 +0100

Most frequent dermoscopic criteria for MIS are regression, atypical network, irregular dots/globules (Source: The Doctors Lounge - Oncology)



Dietary guidelines for children with cancer should change

Fri, 23 Feb 2018 17:27:10 +0100

Research from the University of York has found that attempting to sterilise food does not help prevent infection - and harms children's quality of life. (Source: the Mail online | Health)



Woman becomes sister’s surrogate after breast cancer diagnosis

Fri, 23 Feb 2018 16:57:37 +0100

Randi Fishman was diagnosed with breast cancer at age 28 and didn't think she would ever have kids. (Source: ABC News: Health)



Kazia Receives FDA Orphan Designation for GDC-0084

Fri, 23 Feb 2018 15:57:42 +0100

SYDNEY, Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) ... Biopharmaceuticals, Oncology, FDA Kazia Therapeutics, GDC-0084, glioblastoma multiforme (Source: HSMN NewsFeed)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe

Fri, 23 Feb 2018 15:52:03 +0100

Application Based on Data From Largest International Multiple Myeloma Trial for the Prevention of Skeletal-Related Events Ever Conducted THOUSAND OAKS, Calif., Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announ... Biopharmaceuticals, Oncology, Regulatory Amgen, XGEVA, denosumab, Multiple Myeloma (Source: HSMN NewsFeed)



Woman with cancer organised her wedding inside isolation

Fri, 23 Feb 2018 14:38:24 +0100

Mother-of-two Katie Welsh, now 33, from Manchester, collapsed three days after her boyfriend  Dan Slawycz popped the question while the couple were on a romantic weekend away in February 2016. (Source: the Mail online | Health)



Kidney cancer symptoms: A pain in your side could be a sign of deadly disease

Fri, 23 Feb 2018 13:47:00 +0100

CANCER symptoms usually include an unexplained change in the body ’s normal processes. But, having a pain in your side that doesn’t go away could be a sign of kidney cancer, and you should see a GP. (Source: Daily Express - Health)



IBD Raises Gastrointestinal Cancer Risk IBD Raises Gastrointestinal Cancer Risk

Fri, 23 Feb 2018 13:37:53 +0100

Immunomodulators can intensify cancer risk in patients with bowel disease, despite their control of the underlying inflammation, and new information is emerging on the role of biologics.Medscape Medical News (Source: Medscape Medical News Headlines)



Amgen Receives Positive Opinion Expanding Use Of XGEVA ® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe

Fri, 23 Feb 2018 13:21:09 +0100

Application Based on Data From Largest International Multiple Myeloma Trial for the Prevention of Skeletal-Related Events Ever Conducted THOUSAND OAKS, Calif., Feb. 23, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for XGEVA® (denosumab) to cover skeletal-related events in patients with multiple myeloma. If approved, XGEVA will be indicated for the prevention of skeletal-related events in adults with advanced malignancies involving bone. The application included new data from the Phase 3 '482 study, the largest i... (Source: Amgen News Release)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Stephen Fry recovering from prostate cancer surgery

Fri, 23 Feb 2018 13:00:43 +0100

The presenter had surgery for prostate cancer and says "it all seemed to go pretty well". (Source: BBC News | Health | UK Edition)



Prostate cancer symptoms after shock Stephen Fry diagnosis

Fri, 23 Feb 2018 12:55:00 +0100

PROSTATE cancer symptoms don ’t usually show until the latter stages of the disease. After Stephen Fry was diagnosed with the condition, what are the signs to look out for? (Source: Daily Express - Health)



Woman with cancer organised her wedding inside a bubble  

Fri, 23 Feb 2018 12:51:12 +0100

Mother-of-two Katie Welsh, now 33, from Manchester, collapsed three days after her boyfriend  Dan Slawycz popped the question while the couple were on a romantic weekend away in February 2016. (Source: the Mail online | Health)



EU panel recommends against nod for Puma Biotech's breast cancer drug

Fri, 23 Feb 2018 12:48:55 +0100

(Reuters) - A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology's lead breast cancer drug, an outcome the U.S drugmaker had signaled last month. (Source: Reuters: Health)



Prostate cancer symptoms? How to test for Stephen Fry's condition and treatment to expect

Fri, 23 Feb 2018 12:48:00 +0100

STEPHEN FRY revealed today he has been battling prostate cancer, but what are symptoms of the condition, how can you test for it, and what treatment can you expect? (Source: Daily Express - Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Cameroon:"Many Cancers Are Linked to What We Eat"

Fri, 23 Feb 2018 12:31:33 +0100

[Cameroon Tribune] Professor Jean Marie Kasia, Director General of the Hospital Centre for Applied Research, Endoscopic Surgery and Human Reproduction (CHRACERH). (Source: AllAfrica News: Health and Medicine)



Shocking vaccine safety warning

Fri, 23 Feb 2018 10:49:33 +0100

(Natural News) More than ever, the American population is plagued by debilitating health problems like, Lyme’s disease, chronic fatigue syndrome, autism, cancer and dementia – that were virtually unheard of just a few generations ago. Why? Some say it’s genetics; some say it’s environmental pollution; while others say it’s due to the current (ever-growing) vaccine... (Source: NaturalNews.com)



Cancer Strategy

Fri, 23 Feb 2018 10:42:56 +0100

This debate pack outlines progress so far in implementing the cancer strategy and provides statistics on survival rates and the NHS cancer workforce. It also collates commentary and analysis from official, parliamentary and third sector organisations. (Source: Current Awareness Service for Health (CASH))



Being overweight or having diabetes are both linked to cancer

Fri, 23 Feb 2018 10:30:55 +0100

This NIHR Signal finds that for western high-income countries such as the UK, an estimated 15% to 16% of cancers could be avoided by preventing diabetes, obesity or excess weight. Although the links between high BMI, diabetes and cancer have been known for some time, this study presents the first calculations of attributable risk for 175 countries. This represents the proportion of cancers that could be prevented if the risk factors were eliminated. (Source: Current Awareness Service for Health (CASH))



Mother-of-two who risked cancer started menopause at 32

Fri, 23 Feb 2018 08:07:22 +0100

A Queensland mother-of-two went through menopause at just 32 after she had both of her ovaries removed due to a high-risk of cancer. (Source: the Mail online | Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




MRI-based risk model improves prostate cancer detection

Fri, 23 Feb 2018 07:00:00 +0100

A team of international researchers has successfully tested a risk prediction...Read more on AuntMinnie.comRelated Reading: MRI confirms prostate cancer with lower dose of GBCA Biomarker test could direct MRI use for prostate cancer Luminal water MRI could be best for prostate cancer MRI can replace biopsy for prostate cancer surveillance MRI can help avoid unnecessary prostate cancer biopsies (Source: AuntMinnie.com Headlines)



AIUM to honor ultrasound leaders

Fri, 23 Feb 2018 07:00:00 +0100

The American Institute of Ultrasound in Medicine (AIUM) has announced its 2018...Read more on AuntMinnie.comRelated Reading: AIUM publishes guidance for improving ob/gyn US AIUM: Is MRI really needed after MSK ultrasound? AIUM: Machine learning may aid breast ultrasound reads AIUM: NIH prepares for potential re-emergence of Zika virus AIUM: Contrast US biopsy combo finds high-grade prostate cancer (Source: AuntMinnie.com Headlines)



Malignant Hyperthermia in the Post-Genomics Era Malignant Hyperthermia in the Post-Genomics Era

Fri, 23 Feb 2018 05:14:52 +0100

This review summarizes the latest evidence on the genetics of malignant hyperthermia susceptibility, guidelines for genetic diagnosis, and the limitations of current genetic screening.Anesthesiology (Source: Medscape Today Headlines)



Gemcitabine Plus Sirolimus for Osteosarcoma Gemcitabine Plus Sirolimus for Osteosarcoma

Fri, 23 Feb 2018 05:14:52 +0100

The combination of gemcitabine and sirolimus may be a safe and effective option for patients with relapsed unresectable osteosarcoma.Annals of Oncology (Source: Medscape Today Headlines)



A specific new ELISA method for analyzing cetuximab

Fri, 23 Feb 2018 05:00:00 +0100

This study describes the development and full validation of a new enzyme-linked immunosorbent assay (ELISA) with high sensitivity and selectivity for bioanalysis of CET. (Source: EurekAlert! - Cancer)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Study tracks evolutionary transition to destructive cancer

Fri, 23 Feb 2018 05:00:00 +0100

(Arizona State University) In a new study, researchers at ASU's Biodesign Institute led an international team to explore how evolutionary processes guide the pathways of cells. Their results, which appear in the advanced online edition of the journal Nature Communications, point to influences leading some cells to remain stable over time while driving others to become cancerous and expand without limit. (Source: EurekAlert! - Medicine and Health)



Almost all adolescents in an economically disadvantaged urban population exposed to tobacco smoke

Fri, 23 Feb 2018 05:00:00 +0100

(American Association for Cancer Research) Ninety-four percent of adolescents ages 13 to 19 in an economically disadvantaged, largely minority population in San Francisco had measurable levels of a biomarker specific for exposure to tobacco smoke (NNAL). (Source: EurekAlert! - Cancer)



CDC Director Resigns Amid Reports of Tobacco Stock Trade

Fri, 23 Feb 2018 02:41:46 +0100

The Department of Health and Human Services (HHS) announced on January 31, 2018, that Dr. Brenda Fitzgerald would resign as the Director of the Centers for Disease Control and Prevention (CDC). The statement read, “Dr. Fitzgerald owns certain complex financial interests that have imposed a broad recusal limiting her ability to complete all of her duties as the CDC Director. Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period.” The decision came a day after Politico reported that she bought stock in a large tobacco company within a month of starting her job as the head of the CDC, the agency that oversees programs aimed at reducing tobacco use and smoking. Fitzgerald bought stocks worth tens of thousands of d...



Community outreach winners: Susan Moremen, Sharon Receveur, Lindy Street for Gilda's Club Louisville

Fri, 23 Feb 2018 02:00:00 +0100

In Gilda ’s Club, no one fights cancer alone (Source: bizjournals.com Health Care:Physician Practices headlines)



E-cigarette users at risk of brain and heart damage

Fri, 23 Feb 2018 00:45:02 +0100

E-cigarettes vapor contains metals - including lead - from the heating coils that vaporize e-liquid, putting users at risk of cancer and brain damage, a new study from Johns Hopkins warns. (Source: the Mail online | Health)






Brain cancer research to receive £45m funding

Fri, 23 Feb 2018 00:00:00 +0100

Jeremy Hunt has announced that an estimated £20m in funding will be invested in brain cancer research through the National Institute for Health Research (NIHR) over the next five years. (Source: NHS Networks)



Woman becomes sister ’s surrogate after cancer diagnosis 

Thu, 22 Feb 2018 22:59:40 +0100

Erin Silverman, 35, of Potomac, Maryland, became a surrogate after her sister, Randi Fishman, 34, was diagnosed with breast cancer. Erin gave birth to her sister's baby in December. (Source: the Mail online | Health)



'Mini-tumours' created to battle cancer

Thu, 22 Feb 2018 22:22:56 +0100

The lab-grown versions made from a patient's cancer can predict whether drugs will actually work. (Source: BBC News | Health | UK Edition)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Mini-tumours' created to battle cancer

Thu, 22 Feb 2018 22:22:56 +0100

The lab-grown versions made from a patient's cancer can predict whether drugs will actually work. (Source: BBC News | Health | UK Edition)



Fathers Can Pass Ovarian Cancer Risk To Their Daughters

Thu, 22 Feb 2018 22:00:55 +0100

BOSTON (CBS) – A new study finds that a higher risk of ovarian cancer can be passed from father to daughter. Researchers at the Roswell Park Cancer Institute in Buffalo, NY looked at data from the Familial Ovarian Cancer Registry and discovered a genetic mutation passed from a father to his daughter on the X-chromosome that puts her at higher risk for ovarian cancer. The research team is looking for what the Ovarian Cancer gene looks like. (WBZ-TV) When we think of hereditary ovarian cancer, we often think of the BRCA genes that raise the risk of both ovarian cancer and breast cancer in first degree female relatives, but this is a different gene that can be passed down from the father. This genetic mutation is also associated with a higher risk of prostate cancer in men. Scientists n...



Merck to Buy Australian Viral Immuno-oncology Firm for $394 Million Merck to Buy Australian Viral Immuno-oncology Firm for $394 Million

Thu, 22 Feb 2018 21:45:55 +0100

U.S. drugmaker Merck& Co, already one of the leaders in the hot area of cancer immunotherapy, said on Wednesday it had agreed to buy Viralytics for 502 million Australian dollars ($394 million) to expand its pipeline in the sector.Reuters Health Information (Source: Medscape Allergy Headlines)



Some Outcomes Not Necessarily Better With Robotic Prostate Surgery Some Outcomes Not Necessarily Better With Robotic Prostate Surgery

Thu, 22 Feb 2018 21:45:37 +0100

Men with prostate cancer who get the gland removed may be just as likely to suffer erectile dysfunction and urinary incontinence with robotic surgery as with other operations, a UK study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)



GenX chemical has contaminated the water in North Carolina, residents troubled by lack of information

Thu, 22 Feb 2018 20:48:20 +0100

(Natural News) Like an unfolding nightmare, the area contaminated by cancer-causing GenX continues to grow. The Fayetteville Observer reported that North Carolina officials have once more broadened the area in Bladen County where ground water is at risk. The N.C. Department of Environmental Quality (DEQ) is investigating wells as far as 2 ½ miles from... (Source: NaturalNews.com)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




FDA clears Endomag ’s Magseed marker for long-term and soft tissue implantation

Thu, 22 Feb 2018 20:27:19 +0100

Surgical guidance company Endomag said today that its Magseed magnetic marker won 510(k) clearance from the FDA, extending the product’s indication to include the marking of soft tissue and long-term implantation. The company’s Magseed device is the only wire-free lesion localization device on the market that can be implanted into any soft tissue with no restrictions on how long the marker can remain in the body, according to Endomag. The Magseed marker is 60% smaller than other non-radioactive localization devices, Endomag explained, and is safe to be imaged with ultrasound, X-ray and MRI, under certain conditions. The device, which is smaller than a grain of rice, is designed to be detected by the company’s Sentimag probe. “Our team’s ability to innovate for...



Women who lead in life sciences

Thu, 22 Feb 2018 19:48:47 +0100

The Bay Area life sciences scene has some of the most exciting research going on in the world, and much of it is being led by women. In an industry that is overwhelmingly male at an executive level, the Business Times sought to highlight nearly a dozen women who are either leading their company or part of research that could be the wave of the future. From 3D-printed human organs to microbial genes to cancer treatments, these executives and researchers could have a huge impact in the biotech industry.… (Source: bizjournals.com Health Care:Physician Practices headlines)



Radiomics Model Distinguishes Malignant, Benign Lesions on Mammography Radiomics Model Distinguishes Malignant, Benign Lesions on Mammography

Thu, 22 Feb 2018 19:30:56 +0100

A radiomics model using kurtosis MRI reliably distinguishes between malignant and benign lesions identified as suspicious on mammography.Reuters Health Information (Source: Medscape Radiology Headlines)



Georgia Senate bill would ease limits on Newnan cancer hospital

Thu, 22 Feb 2018 18:36:34 +0100

A new attempt is under way in the General Assembly to ease state regulations on the Cancer Treatment Centers of America hospital in Newnan, Ga., that limit its size and patient mix. (Source: bizjournals.com Health Care:Physician Practices headlines)



Regardless of CV Risks, Cancer History Impacts Mortality

Thu, 22 Feb 2018 18:00:00 +0100

Fibrinogen, von Willebrand factor are potential markers of mortality in cancer survivors (Source: The Doctors Lounge - Oncology)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma

Thu, 22 Feb 2018 17:26:38 +0100

Dr Jeffrey S. Weber reviews data from an open-label phase 1/2 trial assessing the efficacy and safety of combination pembrolizumab and reduced-dose ipilimumab in patients with advanced melanoma.Medscape Oncology (Source: Medscape Today Headlines)



' Moving the Needle' in Oncology Workforce Diversity'Moving the Needle' in Oncology Workforce Diversity

Thu, 22 Feb 2018 17:10:50 +0100

Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce.Medscape Oncology (Source: Medscape Today Headlines)



Practice-Changing Data at 2018 GUCS'Cannot Be Ignored'Practice-Changing Data at 2018 GUCS'Cannot Be Ignored '

Thu, 22 Feb 2018 16:58:45 +0100

A group of practice-changing trials presented at the 2018 Genitourinary Cancers Symposium highlights the growing importance of oncology subspecialty meetings, argues Dr David Graham.Medscape Oncology (Source: Medscape Today Headlines)



Cancer Immunotherapy: Kinder but Not Harmless Cancer Immunotherapy: Kinder but Not Harmless

Thu, 22 Feb 2018 16:23:22 +0100

An expert in immunotherapy for cancer provides a primer on the side effects of drugs targeting the immune system.Medscape Oncology (Source: Medscape Today Headlines)



Adjuvant Chemo in Endometrial Cancer: Benefit Only for Some Adjuvant Chemo in Endometrial Cancer: Benefit Only for Some

Thu, 22 Feb 2018 16:00:31 +0100

PORTEC-3 results show that adjuvant chemotherapy improves failure-free survival, although not overall survival, in women with stage III high-risk endometrial cancer, but not in less advanced disease.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




OncoBreak: Surgical Anxiety; Vets and Tobacco; World-Record Tumor

Thu, 22 Feb 2018 16:00:00 +0100

(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Public Health)



GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer

Thu, 22 Feb 2018 15:52:05 +0100

Decipher testing recognized as standard-of-care in management of prostate cancer patients SAN DIEGO, Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced tha... Diagnostics, Oncology GenomeDx Biosciences, NCCN, Decipher Prostate, Prostate Cancer (Source: HSMN NewsFeed)



Heavy Drinking Is the Biggest Risk Factor for Dementia, Study Says

Thu, 22 Feb 2018 15:48:26 +0100

Hot on the heels of headlines linking alcohol consumption with longer life comes new research that casts a much more sobering light on drinking. According to an analysis of more than 1 million people—the largest study of its kind to date—scientists say that heavy alcohol use is the biggest modifiable risk factor for dementia, especially early-onset forms of the disease. The findings, which are published in The Lancet Public Health, came as a shock to the researchers involved. “We hypothesized that alcohol would play some role, but I don’t think anyone expected the size of the effect to be so large,” says lead author Dr. Jürgen Rehm, director of the University of Toronto’s Center for Addiction and Mental Health Institute for Mental Health Policy Rese...



Varian Acquires Evinance Innovation, Inc.

Thu, 22 Feb 2018 15:41:49 +0100

Expands 360 Oncology care management platform with clinical decision support PALO ALTO, Calif., Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has acquired privately-held Montreal-based Evinance Innovat... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Evinance Innovation, 360 Oncology, radiotherapy (Source: HSMN NewsFeed)



Breast Cancer Survivors: Transition to PCP Leads to Savings Breast Cancer Survivors: Transition to PCP Leads to Savings

Thu, 22 Feb 2018 15:30:20 +0100

Transitioning breast cancer survivors from management by an oncologist to PCP was shown to use fewer health system costs and resources.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




3D tracking of cancers is paving the way for treatments

Thu, 22 Feb 2018 14:24:05 +0100

Researchers from  The Martin Luther University of Halle-Wittenberg in Germany found that producing high-resolution maps could avoid the need for computer programmes that assess tumours. (Source: the Mail online | Health)



Oncologist Awarded $13 Million in Gender Discrimination Lawsuit Oncologist Awarded $13 Million in Gender Discrimination Lawsuit

Thu, 22 Feb 2018 14:23:58 +0100

After working at UCLA for 25 years and heading up the lymphoma program, Lauren Pinter-Brown, MD, claimed she experienced gender discrimination and then retaliation for complaining about it.Medscape Medical News (Source: Medscape Medical News Headlines)



East Bay gene editing company snags Gilead deal worth up to $3.2 billion

Thu, 22 Feb 2018 14:16:27 +0100

Sangamo Therapeutics Inc.'s gene-editing technology is playing second fiddle to CRISPR no longer. The Richmond-based company (NASDAQ: SGMO) Thursday disclosed a deal with Kite, a subsidiary of Foster City-based Gilead Sciences Inc. (NASDAQ: GILD), to develop next-generation cell therapies in cancer. It will receive $150 million upfront but could receive $3 billion more over the course of the c ollaboration by hitting a series of milestones. The deal is a huge win for Sangamo, whose zinc finger nucleases… (Source: bizjournals.com Health Care:Biotechnology headlines)



How artificial intelligence is transforming medicine

Thu, 22 Feb 2018 14:14:37 +0100

Artificial intelligence is part of the new frontier in medicine. In our Grand Round series, Dr. David Agus, who directs research on AI at the University of Southern California and heads USC Norris Westside Cancer Center, joins "CBS This Morning" to discuss how AI is transforming medicine and the risks it poses to patient privacy. (Source: Health News: CBSNews.com)



Skin cancer WARNING: ‘Staggering’ rise in cases - signs that you should see a GP

Thu, 22 Feb 2018 14:02:00 +0100

CANCER symptoms usually include a change to the body ’s normal processes. Skin cancer cases continue to rise in the UK, especially in men. These are the early signs and symptoms to look out for. (Source: Daily Express - Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Tumor Organoids Predict How Well Patients Respond to Cancer Drugs

Thu, 22 Feb 2018 14:00:00 +0100

Testing treatments on mini tumors may save time in identifying which therapies work best, a new study shows. (Source: The Scientist)



Novocure misses Q4 EPS by a penny, tops sales estimates

Thu, 22 Feb 2018 13:40:42 +0100

Shares in Novocure (NSDQ:NVCR) rose slightly today in premarket activity after the medical device maker met sales expectations, but missed earnings estimates on Wall Street with its fourth quarter and full-year financial results. The St. Helier, N.J.-based company reeled in losses this quarter, posting -$10.9 million on sales of $53.7 million for the 3 months ended Dec. 31, for sales growth of 78% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Novocure misses Q4 EPS by a penny, tops sales estimates appeared first on MassDevice. (Source: Mass Device)



QOL Boost Seen From Early, Systematic Palliative Care in Patients With Advanced Solid Tumors

Thu, 22 Feb 2018 13:13:06 +0100

In a Belgian study, integration of palliative care as part of cancer care increased the quality of life of patients with advanced malignant solid tumors. (Source: CancerNetwork)



Sangamo in $3 billion gene-editing deal with Gilead

Thu, 22 Feb 2018 13:06:58 +0100

(Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday. (Source: Reuters: Health)



Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer

Thu, 22 Feb 2018 13:03:57 +0100

Kite to Receive Exclusive License to Leverage Sangamo's Gene Editing Technology in Allogeneic and Autologous Cell Therapy Programs in Oncology SANTA MONICA, Calif. and RICHMOND, Calif., Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Kite, a... Biopharmaceuticals, Oncology, Licensing Sangamo Therapeutics, Kite, Gilead, zinc finger nuclease (Source: HSMN NewsFeed)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Gilead signs $3 billion licensing deal for Sangamo's gene-editing platform

Thu, 22 Feb 2018 12:23:36 +0100

(Reuters) - Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology platform to develop cancer treatments, in a collaboration deal worth more than $3 billion, the two companies said on Thursday. (Source: Reuters: Health)



Sudan:Breast Cancer International Conference to Kick Off in Khartoum Friday

Thu, 22 Feb 2018 11:54:26 +0100

[SNA] Khartoum -The Breast Cancer International Conference will take place in in the Friendship Hall in Khartoum Friday. (Source: AllAfrica News: Health and Medicine)



Novel Tumor-Agnostic Agent: 80% RR, but Target Is Rare Novel Tumor-Agnostic Agent: 80% RR, but Target Is Rare

Thu, 22 Feb 2018 11:48:15 +0100

Oral larotrectinib is highly effective in up to 80% of metastatic solid tumors with a TRK fusion, regardless of patient age or tumor type, but these TRK fusions are rare.Medscape Medical News (Source: Medscape Medical News Headlines)



Monsanto attacks the IARC for labeling glyphosate a probable carcinogen – using the U.S. government as a weapon

Thu, 22 Feb 2018 11:14:18 +0100

(Natural News) U.S. Right to Know recently reported that even though 39 percent of all Americans will one day be diagnosed with cancer, resulting in hundreds of thousands of deaths, government representatives are going out of their way to protect the manufacturers of a known cancer-causer: The glyphosate produced by agri-giant Monsanto. When the World... (Source: NaturalNews.com)



Breast cancer symptoms: Men can test for a cancerous lump using these eight steps

Thu, 22 Feb 2018 09:01:43 +0100

BREAST cancer is usually associated with women, but in rare cases, men can get it too. So how can men test for a cancerous lump? Look out for these signs and symptoms and follow these eight steps. (Source: Daily Express - Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




iKnowMed Ranked Number One Oncology Electronic Health Record by Black Book Research for Seventh Consecutive Year

Thu, 22 Feb 2018 08:00:00 +0100

The Woodlands, Texas (February 22, 2018) — For the seventh consecutive year, iKnowMedSM electronic health record (EHR) has been named the top-ranked EHR platform for oncologists and hematologists by Black BookTM Research, an unbiased industry-leading source for polling, surveys and market research. (Source: McKesson News)



Medical News Today: This specialized gel could improve cancer therapy

Thu, 22 Feb 2018 08:00:00 +0100

Researchers are testing a promising new gel-like medium capable of delivering a combination of therapeutic agents directly to the sites of primary tumors. (Source: Health News from Medical News Today)



CD19 Antibody Targeting With MOR208 Is Active in DLBCL

Thu, 22 Feb 2018 07:25:48 +0100

Single-agent MOR208 showed promising activity with long-lasting responses in aggressive and indolent NHL subtypes, including in rituximab-refractory disease. (Source: CancerNetwork)



Ask How Does Breast Cancer Start

Thu, 22 Feb 2018 07:00:00 +0100

How Does Breast Cancer Start? (Source: eMedicineHealth.com)



New Technology Alone Won ’t Halt Aflatoxin Menace, Experts Warn

Thu, 22 Feb 2018 06:30:19 +0100

Laboratory Technician Herbert Mtopa collects biological samples at a clinic in Zimbabwe's Shamva District under a CultiAF project to assess exposure of women and children to aflatoxins. Credit: Busani Bafana/IPSBy Miriam GathigahNAIROBI, Kenya, Feb 22 2018 (IPS)In the absence of concerted efforts to raise awareness on the dangers of aflatoxin to humans and domestic animals, advances in technology for early detection of aflatoxin in cereals and seeds such as maize will come to naught, experts warn.The first rapid aflatoxin testing kit is in the market for less than two dollars, even as some farmers unwittingly employ life-threatening tricks to earn a bit more from their harvests.John Cheruiyot, a maize farmer in Uasin Gishu County, Rift Valley region revealed to IPS that farmers pour water ...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Impact of 70-Gene Signature Use on Chemo Decisions in BC Impact of 70-Gene Signature Use on Chemo Decisions in BC

Thu, 22 Feb 2018 05:14:49 +0100

Do results of gene-expression profiles change whether patients with ER-positive breast cancer receive adjuvant chemotherapy?Journal of Clinical Oncology (Source: Medscape Today Headlines)



An under-the-radar immune cell shows potential in fight against cancer

Thu, 22 Feb 2018 05:00:00 +0100

(University of British Columbia) One of the rarest of immune cells, Type-2 innate lympoid cells might be a potent weapon in slowing the spread of cancer to other parts of the body. Though known primarily for their role in causing asthma, University of British Columbia scientists found that implanted cancers metastasize much more easily in mice lacking ILC2 cells. (Source: EurekAlert! - Cancer)



Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

Thu, 22 Feb 2018 05:00:00 +0100

(University of California - Riverside) A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases. Until now, paclitaxel has only been used to target rapidly dividing cancer cells. The team was successful in getting the drug to piggyback on 123B9, an agent they devised to target an oncogene called EphA2. (Source: EurekAlert! - Cancer)



UT Dallas scientists isolate cancer stem cells using novel method

Thu, 22 Feb 2018 05:00:00 +0100

(University of Texas at Dallas) Researchers at The University of Texas at Dallas have devised a new technique to isolate aggressive cells thought to form the root of many hard-to-treat metastasized cancers -- a significant step toward developing new drugs that might target these cells. (Source: EurekAlert! - Medicine and Health)



Research to uncover factors behind bladder cancer progression receives ACS grant

Thu, 22 Feb 2018 05:00:00 +0100

(Penn State) To find new therapies for aggressive bladder cancer, researchers must first uncover what drives each subtype at the molecular level. That's why the American Cancer Society has awarded a grant to study bladder cancer development to David DeGraff, assistant professor of pathology, surgery and biochemistry and molecular biology, and a member of Penn State Cancer Institute. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.